The first agreement is related to the transfer of technology required to manufacture the vaccine doses, a Cabinet statement read. Under the agreement, Sinovac will grant VACSERA a limited license to use the manufacturing technology. Last month, Egypt has received its first batch of the raw materials required to produce the Sinovac vaccine. Zayed in a press conference said VACSERA will produce 40 million Sinovac doses in the first year. Egypt is expected to produce the first batch of Sinovac doses by June 15, said Zayed on Sunday.
